Stay updated on ELVN-002 in HER2 NSCLC Clinical Trial
Sign up to get notified when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.

Latest updates to the ELVN-002 in HER2 NSCLC Clinical Trial page
- Check3 days agoChange DetectedMinor site revision from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations updated: new sites across multiple countries added and some existing sites removed; page revision updated to v3.3.3.SummaryDifference1%

- Check54 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0. This appears to be a minor internal version update with no impact on study content or user-facing features.SummaryDifference0.0%

- Check61 days agoChange DetectedThe study site list now includes Tainan, Taiwan, replacing Tainan City, Taiwan, and the government funding status notice was removed.SummaryDifference0.3%

- Check75 days agoChange DetectedThe screenshots show no substantial changes to core study details (conditions, interventions, endpoints, or locations) and any observed differences appear to be minor formatting or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check104 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

Stay in the know with updates to ELVN-002 in HER2 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.